Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly

Depression and Anxiety

Volumn 13, Issue 1, 2001, Pages 38-44

  Bump, Gregory M ^a,b   Mulsant, Benoit H ^a   Pollock, Bruce G ^a   Mazumdar, Sati ^a   Begley, Amy E ^a   Dew, Mary Amanda ^a   Reynolds Iii, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Continuation and maintenance treatment; Depression; Geriatric; Nortriptyline; Paroxetine; Recurrence

Indexed keywords

NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; SIDE EFFECT; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; AGED; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NORTRIPTYLINE; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034965622     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6394(2001)13:1<38::AID-DA6>3.0.CO;2-7     Document Type: Article

References (34)

1. Recovery in geriatric depression
2. Longterm treatment of geropsychiatric depressed patients with venlafaxine
3. Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons
4. Temporal profiles of the course of depression during treatment: Predictors of pathways toward recovery in the elderly
5. An overview of paroxetine in the elderly
6. The effect of treatment on the two-year course of late-life depression
7. Maintenance treatment for recurrent depression in late-life
8. Quantitative determination of paroxetine in plasma by high-performance liquid chromatography
9. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
10. Depression following myocardial infarction. Impact on 6-month survival
11. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients
12. A rating scale for depression
13. Diagnosis and treatment of depression in late-life: Consensus statement update
14. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
15. Cumulative illness rating scale
16. A double-blind placebo-controlled assessment of nortriptyline's side effects during the three-year maintenance treatment in elderly patients with recurrent major depression
17. Maximizing antidepressant compliance in depressed geriatric patients: Cumulative experience from the maintenance therapies in late-life depression study
18. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients
19. Depression: A long-term illness and its treatment
20. Side effects, dropouts from treatment and cost consequences
21. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
22. Epidemiology and diagnosis of depression in late-life
23. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: Six-week outcome
24. NIMH/NIH Consensus Development Conference statement. Mood disorders: Pharmacologic prevention of recurrences
25. How long should the elderly take antidepressants?: A double-blind, placebo-controlled study of continuation/prophylaxis therapy with dothiepin
26. Comparative cardiotoxicity of nortriptyline and its isomeric 10- hydroxymetabolites
27. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
28. Depression and mortality in nursing homes
29. Pharmacologic considerations in the treatment of late-life depression
30. Continuation and maintenance pharmacotherapy in geriatric depression: An open-trial comparison of paroxetine and nortriptyline in patients over age 70
31. Caring for depression in America: Lessons learned from early findings of the Medical Outcomes Study
32. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
33. Predictors of relapse in recurrent affective disorders